Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Algorithm-based reduction and rationalization of antipsychotic polypharmacy in schizophrenia
NL-OMON41978Phase 4Active, not recruiting
- Sponsor
- GGZ Friesland
- Start
- Mar 2015
- Countries
- 1
01
Overview
Phase 4, open-label trial in schizophrenia, schizoaffective disorder and Schizophrenia Spectrum Disorders (SSD) (2 arms), sponsored by GGZ Friesland. Primary endpoint: Personal and social performance. Started Mar 2015; status: active, not recruiting.
02
Conditions
schizophreniaschizoaffective disorderSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON41978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41978.